Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vivamune is a biotechnology and health company focused on developing and commercializing advanced immune-modulating products. The company's primary offering is a proprietary supplement designed to enhance the body's natural immune response and support overall wellness, particularly in the context of inflammation and joint health. Vivamune utilizes a unique blend of bioactive ingredients that target specific pathways in the immune system to promote a balanced and effective defense mechanism. Their products are marketed towards individuals seeking proactive health management and recovery support. The company emphasizes scientific validation and high-quality manufacturing standards for its health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vivamune.